Official: Merck to help produce rival J&J's COVID-19 vaccine
WASHINGTON (AP) — Drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly, a Biden administration official confirmed Tuesday.
The announcement comes as the White House looks to speed the production of the single-dose vaccine. Officials have said J&J faced unexpected production issues with its vaccine and produced only 3.9 million doses ahead of its receiving emergency use authorization on Saturday. The company says it is on pace to deliver 100 million doses by the end of June.
The assistance from Merck was expected to help J&J meet its production commitments and expand supply even further, but the administration did not immediately provide specifics.
President Joe Biden is set to highlight the development in a speech Tuesday afternoon. The official confirmed Merck’s involvement on condition of anonymity ahead of Biden’s public announcement.
The news was first reported by The Washington Post.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
School shooting in Russia kills 8
Another delay in vote to legalize marijuana in Louisiana, bill to be...
As Colonial Pipeline remains offline, 'spotted' fuel outages possible at La. gas...
As businesses struggle to hire workers, organization pushes for end to federal...
Woman shot after finding burglar outside her home; latest in rash of...
LSU pitcher Matt Beck gets his moment at the plate
Brusly baseball needs extra innings to win regional series with Jennings.
Southern Athletic Director Roman Banks talks about coaching search
Drew Brees and Sean Payton enjoy the Zurich Classic
Legendary Parkview coach Kenny Guillot passes away at 76